Literature DB >> 17266546

Structure-activity relationship studies on ADAM protein-integrin interactions.

X Lu1, D Lu, M F Scully, V V Kakkar.   

Abstract

The ADAM (a disintegrin and metalloprotease) family of proteins possess multi-domain structures composed of a signal peptide, a prodomain, a metalloprotease domain, a disintegrin-like domain, a cysteine rich domain, an epidermal growth factor-like domain, a transmembrane domain and cytoplasmic tail. The disintegrin-like domain shares sequence similarity with the soluble venom disintegrins, a family of proteins which are potent inhibitors of integrin-mediated platelet aggregation and cell adhesion. Several ADAMs have been reported to interact with integrins, and the disintegrin-like domain may be crucial part in this respect. A description of structure-activity relationship of ADAM proteins interacting with integrin is outlined in this review. The review highlights recent reports on potential integrin family for ADAMs and how ADAMs selectively modulate interaction for integrin mediated cell function. Lastly, it describes progress in understanding the structural features and functional roles of the ADAMs in normal and pathological conditions and how this insight may assist the development of new therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17266546     DOI: 10.2174/187152507779315822

Source DB:  PubMed          Journal:  Cardiovasc Hematol Agents Med Chem        ISSN: 1871-5257


  8 in total

1.  Structural characterization of the ectodomain of a disintegrin and metalloproteinase-22 (ADAM22), a neural adhesion receptor instead of metalloproteinase: insights on ADAM function.

Authors:  Heli Liu; Ann H R Shim; Xiaolin He
Journal:  J Biol Chem       Date:  2009-08-18       Impact factor: 5.157

2.  Strain-induced differentiation of fetal type II epithelial cells is mediated via the integrin α6β1-ADAM17/tumor necrosis factor-α-converting enzyme (TACE) signaling pathway.

Authors:  Yulian Wang; Zheping Huang; Pritha S Nayak; Benjamin D Matthews; David Warburton; Wei Shi; Juan Sanchez-Esteban
Journal:  J Biol Chem       Date:  2013-07-25       Impact factor: 5.157

3.  A novel family of RGD-containing disintegrins (Tablysin-15) from the salivary gland of the horsefly Tabanus yao targets αIIbβ3 or αVβ3 and inhibits platelet aggregation and angiogenesis.

Authors:  D Ma; X Xu; S An; H Liu; X Yang; J F Andersen; Y Wang; F Tokumasu; J M C Ribeiro; I M B Francischetti; R Lai
Journal:  Thromb Haemost       Date:  2011-04-07       Impact factor: 5.249

Review 4.  Regulation of thrombospondin1 by extracellular proteases.

Authors:  M Luisa Iruela-Arispe
Journal:  Curr Drug Targets       Date:  2008-10       Impact factor: 3.465

5.  ADAM2 interactions with mouse eggs and cell lines expressing α4/α9 (ITGA4/ITGA9) integrins: implications for integrin-based adhesion and fertilization.

Authors:  Ulyana V Desiderio; Xiaoling Zhu; Janice P Evans
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

6.  Thrombin-cleaved fragments of osteopontin are overexpressed in malignant glial tumors and provide a molecular niche with survival advantage.

Authors:  Yasuto Yamaguchi; Zhifei Shao; Shadi Sharif; Xiao-Yan Du; Timothy Myles; Milton Merchant; Griffith Harsh; Michael Glantz; Lawrence Recht; John Morser; Lawrence L K Leung
Journal:  J Biol Chem       Date:  2012-11-30       Impact factor: 5.157

7.  Regulation of mature ADAM17 by redox agents for L-selectin shedding.

Authors:  Yue Wang; Amy H Herrera; Ying Li; Kiran K Belani; Bruce Walcheck
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

Review 8.  ADAM-15 disintegrin-like domain structure and function.

Authors:  Dong Lu; Mike Scully; Vijay Kakkar; Xinjie Lu
Journal:  Toxins (Basel)       Date:  2010-10-19       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.